Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Why use automatic rebalancing? It helps maintain risk targets, lowers discipline gaps, and frees you from constant manual monitoring.
22,122 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Bitcoin briefly rose above $65k but failed to hold, with on-chain data showing selling pressure from both new buyers ...
A 72-year-old retiree confronts a surprise $19,000 tax bill on his first Required Minimum Distribution, underscoring ...
Tesla is signaling stronger profit margins and robust cash flow, setting up a potential 12% rally in the coming year....
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...
New York billionaire Bill Ackman launches a $260 million brain research center on the Upper West Side after a family ...
Capital Group's Dividend Value ETF has significantly outperformed SCHD since February 2022, prompting renewed debate ...
Investors looking for steady upside in a volatile market often turn to utility leaders. Here are three durable cataly...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
Two SUI spot ETFs kicked off trading in the U.S. on Feb. 18, 2026, yet debut volume was muted. The scene highlights t...
A Seattle federal court is weighing Zillow's bid to dismiss a consolidated RESPA lawsuit accusing the company of stee...
Global X's XYLD ETF continues to deliver monthly payouts through a covered-call strategy, but a persistent drag on to...